Taiwan FDA registration 7f351acb7055ed4dc615971357467880
Wuding uric acid two-grade tube solution (not sterilized)
TW: 五鼎尿酸二品管液(未滅菌)
Taiwan·Risk Class 1·APEX BIOTECHNOLOGY CORPORATION·Registered Mar 28, 2022 – Mar 28, 2027ActiveRegistration details
- Analysis ID
- 7f351acb7055ed4dc615971357467880
Company information
- Manufacturer
- APEX BIOTECHNOLOGY CORPORATION
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- APEX BIOTECHNOLOGY CORPORATION
Product details
- Intended Use
- Limited to the classification and grading management of medical equipment, quality control materials (analytical and non-analytical) (A.1660) the first level identification range.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1660 Quality control materials (analytical and non-analytical)
- Import Information
- QMS/QSD;; 國產
Dates and status
- Registration Date
- Mar 28, 2022
- Expiry Date
- Mar 28, 2027
About this record
Access comprehensive regulatory information for Wuding uric acid two-grade tube solution (not sterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 7f351acb7055ed4dc615971357467880 and manufactured by APEX BIOTECHNOLOGY CORPORATION. The authorized representative in Taiwan is APEX BIOTECHNOLOGY CORPORATION.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices